HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

FP 736-04

an iodinated hepatocyte-specific contrast medium for the CT of liver

Also Known As:

FP-736-04

Networked: 6 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Bergman, A: 1 article (11/2000)
2.	Magnusson, A: 1 article (11/2000)

Related Diseases

1.	Liver Diseases (Liver Disease) 04/01/1998 - "Efficacy of the hepatocyte-specific contrast medium FP 736-04 for CT in two models of experimental diffuse liver disease."
2.	Experimental Liver Cirrhosis 09/01/1998 - "The efficacy of FP 736-04 in experimental liver cirrhosis."
3.	Fatty Liver 05/01/1997 - "The uptake of FP 736-04 by the fatty liver was significantly reduced, yielding a maximum enhancement of 22.3 +/- 7.9 HU as compared to a value of 32.3 +/- 5.0 HU in the control group. " 05/01/1997 - "CT with the hepatocyte-specific contrast medium FP 736-04 in an experimental model of liver steatosis." 01/01/1997 - "In cases of fatty liver infiltration, enhancement by FP 736-04 was significantly reduced as compared with normal controls. "
4.	Starvation 11/01/2000 - "A pre-examination period of starvation had no effect on FP 736-04 liver enhancement on CT However, liver attenuation tended to decrease more slowly in the starvation group than in the controls." 11/01/2000 - "A control group was subjected to the same CT examination protocol with use of FP 736-04 but without prior starvation. " 11/01/2000 - "Influence of pre-examination starvation on liver uptake of the hepatocyte-specific contrast medium FP 736-04 at CT. " 11/01/2000 - "To investigate the effect of starvation on contrast-enhanced CT of the liver using the iodinated hepatocyte-specific lipid emulsion FP 736-04. "
5.	Neoplasm Metastasis (Metastasis) 11/01/1997 - "Relationship between contrast enhancement and diagnostic accuracy with the liver-specific CT contrast medium FP 736-04 in an experimental model of liver metastases."

Related Drugs and Biologics

1.	Lipids
2.	Emulsions